SynthesisFrontiers in dental medicine2026
Prevalence of the second mesiobuccal canal of maxillary molars in the South American population: a systematic review and meta-analysis of CBCT studies.
Synthesis in Frontiers in dental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The objective of this systematic review and meta-analysis was to determine the prevalence of the second mesiobuccal (MB2) canal in permanent maxillary molars within the South American population, evaluated exclusively through cone-beam computed tomography (CBCT). Methods: Following the PRISMA guidelines, an electronic search was conducted across PubMed, Scopus, Web of Science, Embase, SciELO, LILACS, and gray literature until May 2026. Observational studies published from 1990 onwards were included. A meta-analysis of proportions was executed using a random-effects model. The risk of bias was assessed with the JBI tool, and the certainty of evidence using the GRADE framework. Results: A total of 23 observational studies were included. The pooled overall prevalence of the MB2 canal was 59% (95% CI: 53%-66%). In the tooth-specific analysis, prevalence reached 66% in first molars and 41% in second molars. Significant sexual dimorphism was evident in second molars, where males presented a 35% higher probability of possessing the canal (OR = 1.35). The GRADE analysis indicated a High certainty for the overall and first molar prevalences, and Moderate for second molars. Conclusions: The MB2 canal is a highly prevalent anatomical variation in South America, constituting the anatomical norm in first molars. The clinical use of CBCT is crucial for its diagnostic prediction and successful management. Systematic Review Registration: DOI: 10.17605/OSF.IO/KRG4Z.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.